Another study by Shimizu et al. also supported that ASCT2 was significantly overexpressed in NSCLC, which correlated with advanced disease stage, lymphatic permeation, vascular invasion, increased cell proliferation, angiogenesis, and mTOR phosphorylation [195]. Here, SLC1A5 is linked to non-small cell lung carcinoma.